Asset Details
Do you wish to reserve the book?
More Than the Sum of the Respiratory Events: Personalized Medicine Approaches for Obstructive Sleep Apnea
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
More Than the Sum of the Respiratory Events: Personalized Medicine Approaches for Obstructive Sleep Apnea
Do you wish to request the book?
More Than the Sum of the Respiratory Events: Personalized Medicine Approaches for Obstructive Sleep Apnea
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
More Than the Sum of the Respiratory Events: Personalized Medicine Approaches for Obstructive Sleep Apnea
2019
Overview
Abstract
Traditionally, the presence and severity of obstructive sleep apnea (OSA) have been defined by the apnea–hypopnea index (AHI). Continuous positive airway pressure is generally first-line therapy despite low adherence, because it reliably reduces the AHI when used, and the response to other therapies is variable. However, there is growing appreciation that the underlying etiology (i.e., endotype) and clinical manifestation (i.e., phenotype) of OSA in an individual are not well described by the AHI. We define and review the important progress made in understanding and measuring physiological mechanisms (or endotypes) that help define subtypes of OSA and identify the potential use of genetics to further refine disease classification. This more detailed understanding of OSA pathogenesis should influence clinical treatment decisions as well as help inform research priorities and clinical study design. In short, treatments could be individualized on the basis of the underlying cause of OSA; patients could better understand which symptoms and outcomes will respond to OSA treatment and by how much; and researchers could select populations most likely to benefit from specific treatment approaches for OSA.
Publisher
Oxford University Press,American Thoracic Society
Subject
/ Aged
/ Concise Translational Review
/ Continuous positive airway pressure
/ Continuous Positive Airway Pressure - standards
/ Diabetes
/ Female
/ Genetic Predisposition to Disease
/ Genotype
/ Humans
/ Insulin
/ Male
/ NMR
/ Patients
/ Practice Guidelines as Topic
/ Precision Medicine - standards
